Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v3-FR
Language English French
Date Updated 2023-11-16 2023-01-25
Drug Identification Number 00028096 00028096
Brand name CELESTONE SOLUSPAN CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients BETAMETHASONE BETAMETHASONE ACETATE BETAMETHASONE BETAMETHASONE ACETATE
Strength(s) 3MG 3MG 3MG 3MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR
Packaging size 5ML VIAL 5ML VIAL
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-04-21 2023-05-05
Actual start date 2023-03-29
Estimated end date 2023-11-17 2023-05-26
Actual end date 2023-11-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments